Global ChIP-Sequencing Market, By Technology (Targeted Sequencing and Re-Sequencing, Whole Genome Sequencing, and Whole Exome Sequencing), End-User (Academic Research Institutes, Clinical Research Institutes, Hospitals and Clinics, Pharmaceuticals and Biotechnology Companies, and Others), Workflow (Pre-Sequencing, Sequencing and Data analysis) - Industry Trends and Forecast to 2030.
ChIP- Sequencing Market Analysis and Size
The global ChIP-sequencing market is expected to grow significantly during the forecast period. Chromatin immunoprecipitation sequencing helps researchers screen and identify protein binding sites across the chromosomal scale with high accuracy and efficiency. ChIP sequencing maps the protein of interest to a global binding site. Chip-on-chip was the most commonly used technique for studying proteins and DNA relationships.
Data Bridge Market Research analyses that the myositis treatment market, which was USD 10.78 billion in 2022, would rocket up to USD 23.26 billion by 2030 and is expected to undergo a CAGR of 10.8% during the forecast period of 2023 to 2030. “whole genome sequencing” dominates the technology segment of the ChIP Sequencing market owing to the increasing prevalence of immunological cases among the population.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
ChIP- Sequencing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Technology (Targeted Sequencing and Re-Sequencing, Whole Genome Sequencing, and Whole Exome Sequencing), End-User (Academic Research Institutes, Clinical Research Institutes, Hospitals and Clinics, Pharmaceuticals and Biotechnology Companies, and Others), Workflow (Pre-Sequencing, Sequencing and Data analysis)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, rest of South America
|
|
Market Players Covered
|
|
|
Market Opportunities
|
|
Market Definition
Chromatin immunoprecipitation sequencing or ChIP-sequencing is used to demonstrate DNA-protein interactions using next generation sequencing. Chromatin immunoprecipitation is combined with DNA sequencing to identify binding sites for DNA-related proteins. It is a tool that helps determine the location of DNA binding sites on the genome of a protein of interest.
ChIP- Sequencing Market Dynamics
Drivers
- Increasing technological advancements
Continued technological advances in sequencers have enabled the development of efficient, portable, and easy-to-use NGS platforms that deliver fast and accurate results while reducing turnaround times. Introducing such products and the technologies that support them gives players an immediate competitive advantage. As a result, large companies are increasingly focusing on product research and development to increase their market position and share. Therefore, this will contribute to the market's growth during the forecast period.
- Increasing application in drug discovery and development
Chip sequencing is essential to the process of developing new drugs. It supports the analysis of drug response variability and optimizing therapeutic interventions by identifying possible pharmacological targets. Chip sequencing is becoming a crucial research and development tool as pharmaceutical companies seek more effective and targeted methods for creating new medications.
- Rising immunological cases
Comprehensive genomic analyses given by chip sequencing are becoming increasingly necessary due to the rising occurrence of immunological disorders, such as autoimmune illnesses, allergies, and immunodeficiencies. It helps scientists and medical professionals to comprehend the molecular mechanisms behind immunological illnesses in greater depth, resulting in enhanced diagnoses, targeted treatments, and personalized medicine methods. As a result, the worldwide chip sequencing market is anticipated to gain from this increased demand and improve the scope of its immunology-related applications.
Opportunities
- Increasing funding for research and clinical activities
Government and private funding for large-scale sequencing presents significant opportunities for the Next-Generation Sequencing (NGS) market. Many countries are investing in their demographic programs to better understand the relationship between genetics and disease. Government groups have sequenced millions of genomes to advance research and find better ways to detect and treat cancer, abnormal illnesses, and other illnesses. Given the large-scale deployment of NGS equipment and the use of consumables needed for such efforts, large-scale sequencing projects are expected to create growth prospects in favor of market players.
- Growing demand for personalized medicine
Personalized medicine aims to offer customized treatments based on a person's genetic profile. Chip sequencing is vital to the analysis of genetic information, the discovery of genetic variants, and the development of personalized treatment. The chip sequencing industry is anticipated to be an opportunity by the rising need for personalized medicines.
- Expansion of pharmaceutical and biotechnology companies
The pharmaceutical and biotechnology industries are constantly looking for fresh perspectives on disease causes, identifying biomarkers, and creating new medications. Chip sequencing can help locate prospective drug targets, comprehend the heterogeneity of pharmacological responses, and enhance therapeutic approaches. The chip sequencing market will expand as these sectors develop.
Challenges/ Restraints
- Strict regulatory framework
Compliance and regulatory systems govern chip sequencing and other aspects of genomics These restrictions may differ between nations or regions, making it difficult for global market actors to navigate confusing regulatory environments and guarantee adherence to rules governing data protection and research ethics.
- High cost of ChiP Sequencing
Chip sequencing technology, including the necessary hardware, supplies, and data analysis software, can be expensive. Chip sequencing's adoption may be constrained by its expense, particularly for universities with lower budgets or research labs. The high cost of chip sequencing may act as a barrier to entry and prevent the technology from becoming widely used.
- Alternative technologies
RNA sequencing (RNA-seq) and single-cell sequencing are two competitive alternatives to chip sequencing despite chip sequencing's strength. These other technologies have their benefits and occasionally give additional insights. Depending on their individual research goals, researchers may select different sequencing techniques, which could impact the adoption of chip sequencing.
- Lack of skilled workforce
Large volumes of data produced by chip sequencing necessitate sophisticated bioinformatics processing. However, there is a shortage of qualified experts in data analysis, computational biology, and bioinformatics. The development and application of chip sequencing technologies are hampered by the lack of experts who can efficiently analyze chip sequencing data and derive valuable insights.
This ChIP-sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ChIP-sequencing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global ChIP Sequencing Market Scope
The ChIP-sequencing market is segmented on the basis of technology, workflow, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Targeted Sequencing and Re-Sequencing
- Whole Genome Sequencing and Whole Exome Sequencing
End-User
- Academic Research Institutes
- Clinical Research Institutes
- Hospitals and Clinics
- Pharmaceuticals and Biotechnology Companies
- Others
Workflow
- Pre-Sequencing
- Sequencing
- Data analysis
ChIP- Sequencing Market Regional Analysis/Insights
The ChIP-sequencing market is analyzed and market size insights and trends are provided by technology, workflow, and end-user as referenced above.
The major countries covered in the ChIP-sequencing market report are the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, rest of South America.
North America is expected to dominate the market due to the rising government support for research and development.
Asia-Pacific is expected to grow from 2023 to 2030 due to high investment in India and China in research and development of next-generation sequencing.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The ChIP- Sequencing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ChIP sequencing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on market. The data is available for the historic period 2015-2020.
Competitive Landscape and ChIP Sequencing Market Share Analysis
The ChIP-sequencing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the ChIP- sequencing market are:
- Illumina, Inc. (U.S.)
- Thermo Fisher Scientific, Inc. (U.S.)
- PerkinElmer Inc. (U.S.)
- BGI Group (China)
- Agilent Technologies Inc. (U.S.)
- Eurofins Scientific SE (Luxembourg)
- PacBio (U.S.)
- Oxford Nanopore Technologies plc (U.K.)
- QIAGEN (Netherlands)
- F. Hoffmann-La Roche Ltd (Switzerland)
- GENEWIZ, Inc., (U.S.)
- Psomagen (South Korea)
- 10x Genomics Inc. (U.S.)
- Takara Bio (Japan)
- Zymo Research (U.S.)
- Hamilton Company (U.S.)
- BD (U.S.)
- Novogene Co., Ltd. (China)
SKU-